Guglielmi F W, Boggio-Bertinet D, Federico A, Forte G B, Guglielmi A, Loguercio C, Mazzuoli S, Merli M, Palmo A, Panella C, Pironi L, Francavilla A
Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.
Dig Liver Dis. 2006 Sep;38(9):623-42. doi: 10.1016/j.dld.2006.04.002. Epub 2006 Jun 12.
Total parenteral nutrition is a life saving therapy for patients with chronic gastrointestinal failure, being an effective method for supplying energy and nutrients when oral or enteral feeding is impossible or contraindicated. Clinical epidemiological data indicate that total parenteral nutrition may be associated with a variety of problems. Herein we reviewed data on the gastroenterological tract regarding: (i) total parenteral nutrition-related hepatobiliary complications; and (ii) total parenteral nutrition-related intestinal complications. In the first group, complications may vary from mildly elevated liver enzyme values to steatosis, steatohepatitis, cholestasis, fibrosis and cirrhosis. In particular, total parenteral nutrition is considered to be an absolute risk factor for the development of biliary sludge and gallstones and is often associated with hepatic steatosis and intrahepatic cholestasis. In general, the incidence of total parenteral nutrition-related hepatobiliary complications has been reported to be very high, ranging from 20 to 75% in adults. All these hepatobiliary complications are more likely to occur after long-term total parenteral nutrition, but they seem to be less frequent, and/or less severe in patients who are also receiving oral feeding. In addition, end-stage liver disease has been described in approximately 15-20% of patients receiving prolonged total parenteral nutrition. Total parenteral nutrition-related intestinal complications have not yet been adequately defined and described. Epidemiological studies intended to define the incidence of these complications, are still ongoing. Recent papers confirm that in both animals and humans, total parenteral nutrition-related intestinal complications are induced by the lack of enteral stimulation and are characterised by changes in the structure and function of the gut. Preventive suggestions and therapies for both these gastroenterological complications are reviewed and reported in the present review.
全胃肠外营养是慢性胃肠功能衰竭患者的一种挽救生命的治疗方法,是在无法进行口服或肠内喂养或存在禁忌证时提供能量和营养的有效方法。临床流行病学数据表明,全胃肠外营养可能与多种问题相关。在此,我们回顾了有关胃肠道的以下数据:(i)与全胃肠外营养相关的肝胆并发症;以及(ii)与全胃肠外营养相关的肠道并发症。在第一组中,并发症的范围可从肝酶值轻度升高到脂肪变性、脂肪性肝炎、胆汁淤积、纤维化和肝硬化。特别是,全胃肠外营养被认为是胆泥和胆结石形成的绝对危险因素,并且常与肝脂肪变性和肝内胆汁淤积相关。一般而言,据报道与全胃肠外营养相关的肝胆并发症的发生率非常高,在成年人中为20%至75%。所有这些肝胆并发症在长期全胃肠外营养后更易发生,但在同时接受口服喂养的患者中似乎发生率较低和/或程度较轻。此外,在接受长期全胃肠外营养的患者中,约15%至20%出现了终末期肝病。与全胃肠外营养相关的肠道并发症尚未得到充分定义和描述。旨在确定这些并发症发生率的流行病学研究仍在进行中。最近的论文证实,在动物和人类中,与全胃肠外营养相关的肠道并发症是由缺乏肠内刺激引起的,其特征是肠道结构和功能的改变。本综述对这两种胃肠并发症的预防建议和治疗方法进行了回顾和报道。